Home » Topics » Regulatory

Regulatory
RSS

Chiesi's budesonide Modulite pMDI approved in Germany

Jan. 21, 2003

Novartis seeks approval for lower dose of Estalis in Sweden

Jan. 21, 2003

Caelyx approved in E.U. for metastatic breast cancer

Jan. 16, 2003

Aventis Behring submits BLA for i.v. alpha1-proteinase inhibitor

Jan. 16, 2003

Approval of Coreg recommended for heart attack patients with impaired cardiac function

Jan. 15, 2003

Infliximab granted priority review by the FDA for fistulizing CD

Jan. 13, 2003

Type 2 diabetic patients complete first six-month treatment course with Metformin GR

Jan. 13, 2003

A potential new indication proposed for losartan

Jan. 10, 2003

Prozac approved for pediatric depression and OCD

Jan. 9, 2003

FDA approves Singulair for seasonal allergic rhinitis

Jan. 9, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...